Intramedullary Nail Versus Hip Arthroplasty in Unstable Trochanteric Hip Fractures

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age65-120
SponsorHelse Stavanger HF

About this trial

A hip fracture is a large burden to the patient with increased mortality, pain and increased need for daily assistance. Trochanteric fractures of the femur (FTF) represents about 35% of the hip fractures. Today FTFs are mainly treated with internal fixation using sliding hips screws (SHS) or intramedullary nail (IMN), whilst hip arthroplasty (THA/HA) is rarely used. Despite advances in the design of the internal fixation implants there is a high failure rate, in particular in cases of FTFs classified as unstable fractures. Since the introduction of hip arthroplasty in femoral neck fractures there has been a reduction in complication rates, early mobilization and shorter hospital stays.

The primary objective of this project is to investigate if treatment with hip arthroplasty in unstable FTFs will increase the postoperative mobility, give a better general health outcome for the patient, better quality of life and reduce re-operation rate for the patients compared to those operated with the traditional IMN.

Eligibility criteria

Qualifiers

Age ≥ 65 years

American Society of Anesthesiology Score (ASA) < 4

Ambulant with or without aid (preinjury)

Radiological verified unstable trochanteric hip fracture (AO 31A2.2 - 3.3)

Disqualifiers

Previous hip surgery on ipsilateral or contralateral side

Non-ambulant preinjury

Patient not living in the area of hospital care

Trial design

Treatments tested in this trial

  • Intramedullary nail
  • Hip arthroplasty

Treatment groups

170 Participants
are divided into 2 treatment groups

Sponsors and collaborators